News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Pine Michael Craig
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/30/2023 |
4
| Pine Michael Craig (Chief Corp Dev.&Strat. Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $5.93, valued at
$89k
Granted 7,500 restricted stock units
@ $0 |
|
| 01/10/2023 |
4
| Pine Michael Craig (Chief Corp Dev.&Strat. Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 91,655 options to buy
@ $3.26, valued at
$298.8k
|
|
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2022 |
3
| Pine Michael Craig (Chief Corp Dev.&Strat. Officer) has filed a Form 3 on EyePoint Pharmaceuticals, Inc. |
| 01/14/2022 |
4
| Pine Michael Craig (Chief Corp Dev.&Strat. Officer) has filed a Form 4 on EyePoint Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $12.62, valued at
$1.3M
|
|
|
|